A detailed history of Andrew Hill Investment Advisors, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Andrew Hill Investment Advisors, Inc. holds 7,590 shares of UTHR stock, worth $2.74 Million. This represents 2.18% of its overall portfolio holdings.

Number of Shares
7,590
Holding current value
$2.74 Million
% of portfolio
2.18%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$311.04 - $363.55 $2.36 Million - $2.76 Million
7,590 New
7,590 $2.72 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Andrew Hill Investment Advisors, Inc. Portfolio

Follow Andrew Hill Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andrew Hill Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Andrew Hill Investment Advisors, Inc. with notifications on news.